Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 92

1.

iEDDA Conjugation Reaction in Radiometal Labeling of Peptides with 68Ga and 64Cu: Unexpected Findings.

Litau S, Seibold U, Wängler B, Schirrmacher R, Wängler C.

ACS Omega. 2018 Oct 31;3(10):14039-14053. doi: 10.1021/acsomega.8b01926. Epub 2018 Oct 25.

2.

Design, Synthesis, In Vitro, and Initial In Vivo Evaluation of Heterobivalent Peptidic Ligands Targeting Both NPY(Y₁)- and GRP-Receptors-An Improvement for Breast Cancer Imaging?

Vall-Sagarra A, Litau S, Decristoforo C, Wängler B, Schirrmacher R, Fricker G, Wängler C.

Pharmaceuticals (Basel). 2018 Jul 4;11(3). pii: E65. doi: 10.3390/ph11030065.

3.

Design, synthesis and in vitro evaluation of heterobivalent peptidic radioligands targeting both GRP- and VPAC1-Receptors concomitantly overexpressed on various malignancies - Is the concept feasible?

Lindner S, Fiedler L, Wängler B, Bartenstein P, Schirrmacher R, Wängler C.

Eur J Med Chem. 2018 Jul 15;155:84-95. doi: 10.1016/j.ejmech.2018.05.047. Epub 2018 May 29.

PMID:
29864700
4.

Analyses of Synthetic N-Acyl Dopamine Derivatives Revealing Different Structural Requirements for Their Anti-inflammatory and Transient-Receptor-Potential-Channel-of-the-Vanilloid-Receptor-Subfamily-Subtype-1 (TRPV1)-Activating Properties.

Pallavi P, Pretze M, Caballero J, Li Y, Hofmann BB, Stamellou E, Klotz S, Wängler C, Wängler B, Loesel R, Roth S, Theisinger B, Moerz H, Binzen U, Greffrath W, Treede RD, Harmsen MC, Krämer BK, Hafner M, Yard BA, Kälsch AI.

J Med Chem. 2018 Apr 12;61(7):3126-3137. doi: 10.1021/acs.jmedchem.8b00156. Epub 2018 Apr 2.

PMID:
29543451
5.

Gastrin-Releasing Peptide Receptor- and Prostate-Specific Membrane Antigen-Specific Ultrasmall Gold Nanoparticles for Characterization and Diagnosis of Prostate Carcinoma via Fluorescence Imaging.

Pretze M, Hien A, Rädle M, Schirrmacher R, Wängler C, Wängler B.

Bioconjug Chem. 2018 May 16;29(5):1525-1533. doi: 10.1021/acs.bioconjchem.8b00067. Epub 2018 Mar 27.

PMID:
29542916
6.

Recent Advances in 18F Radiochemistry: A Focus on B-18F, Si-18F, Al-18F, and C-18F Radiofluorination via Spirocyclic Iodonium Ylides.

Bernard-Gauthier V, Lepage ML, Waengler B, Bailey JJ, Liang SH, Perrin DM, Vasdev N, Schirrmacher R.

J Nucl Med. 2018 Apr;59(4):568-572. doi: 10.2967/jnumed.117.197095. Epub 2017 Dec 28.

PMID:
29284673
7.

Identification of [18F]TRACK, a Fluorine-18-Labeled Tropomyosin Receptor Kinase (Trk) Inhibitor for PET Imaging.

Bernard-Gauthier V, Mossine AV, Mahringer A, Aliaga A, Bailey JJ, Shao X, Stauff J, Arteaga J, Sherman P, Grand'Maison M, Rochon PL, Wängler B, Wängler C, Bartenstein P, Kostikov A, Kaplan DR, Fricker G, Rosa-Neto P, Scott PJH, Schirrmacher R.

J Med Chem. 2018 Feb 22;61(4):1737-1743. doi: 10.1021/acs.jmedchem.7b01607. Epub 2018 Jan 5.

PMID:
29257860
8.

Synthesis, in vitro and in vivo evaluation of 18F-fluoronorimatinib as radiotracer for Imatinib-sensitive gastrointestinal stromal tumors.

Prause M, Niedermoser S, Wängler C, Decristoforo C, Seibold U, Riester S, Taguchi T, Schirrmacher R, Fricker G, Wängler B.

Nucl Med Biol. 2018 Feb;57:1-11. doi: 10.1016/j.nucmedbio.2017.11.004. Epub 2017 Nov 17.

PMID:
29175467
9.

[18F]-Fluorodeoxyglucose-Positron Emission Tomography in Rats with Prolonged Cocaine Self-Administration Suggests Potential Brain Biomarkers for Addictive Behavior.

Cannella N, Cosa-Linan A, Roscher M, Takahashi TT, Vogler N, Wängler B, Spanagel R.

Front Psychiatry. 2017 Nov 1;8:218. doi: 10.3389/fpsyt.2017.00218. eCollection 2017.

10.

Small Prosthetic Groups in 18F-Radiochemistry: Useful Auxiliaries for the Design of 18F-PET Tracers.

Schirrmacher R, Wängler B, Bailey J, Bernard-Gauthier V, Schirrmacher E, Wängler C.

Semin Nucl Med. 2017 Sep;47(5):474-492. doi: 10.1053/j.semnuclmed.2017.07.001. Epub 2017 Jul 17. Review.

PMID:
28826522
11.

Rational Design, Development, and Stability Assessment of a Macrocyclic Four-Hydroxamate-Bearing Bifunctional Chelating Agent for 89 Zr.

Seibold U, Wängler B, Wängler C.

ChemMedChem. 2017 Sep 21;12(18):1555-1571. doi: 10.1002/cmdc.201700377. Epub 2017 Sep 8.

PMID:
28715615
12.

A Kinome-Wide Selective Radiolabeled TrkB/C Inhibitor for in Vitro and in Vivo Neuroimaging: Synthesis, Preclinical Evaluation, and First-in-Human.

Bernard-Gauthier V, Bailey JJ, Mossine AV, Lindner S, Vomacka L, Aliaga A, Shao X, Quesada CA, Sherman P, Mahringer A, Kostikov A, Grand'Maison M, Rosa-Neto P, Soucy JP, Thiel A, Kaplan DR, Fricker G, Wängler B, Bartenstein P, Schirrmacher R, Scott PJH.

J Med Chem. 2017 Aug 24;60(16):6897-6910. doi: 10.1021/acs.jmedchem.7b00396. Epub 2017 Jul 21.

PMID:
28696690
13.

Investigation of the imaging characteristics of the ALBIRA II small animal PET system for 18F, 68Ga and 64Cu.

Attarwala AA, Karanja YW, Hardiansyah D, Romanó C, Roscher M, Wängler B, Glatting G.

Z Med Phys. 2017 Jun;27(2):132-144. doi: 10.1016/j.zemedi.2017.01.005. Epub 2017 Apr 13.

PMID:
28412013
14.

Evaluation of two nucleophilic syntheses routes for the automated synthesis of 6-[18F]fluoro-l-DOPA.

Pretze M, Franck D, Kunkel F, Foßhag E, Wängler C, Wängler B.

Nucl Med Biol. 2017 Feb;45:35-42. doi: 10.1016/j.nucmedbio.2016.10.007. Epub 2016 Oct 27.

PMID:
27886621
15.

Targeting Gastrointestinal Stromal Tumor with 68Ga-Labeled Peptides: An In Vitro Study on Gastrointestinal Stromal Tumor-Cell Lines.

Paulmichl A, Summer D, Manzl C, Rangger C, Orlandi F, Niedermoser S, Taguchi T, Wängler B, Decristoforo C.

Cancer Biother Radiopharm. 2016 Oct;31(8):302-310.

PMID:
27754750
16.

Radiofluorinated N-Octanoyl Dopamine ([18F]F-NOD) as a Tool To Study Tissue Distribution and Elimination of NOD in Vitro and in Vivo.

Pretze M, Pallavi P, Roscher M, Klotz S, Caballero J, Binzen U, Greffrath W, Treede RD, Harmsen MC, Hafner M, Yard B, Wängler C, Wängler B.

J Med Chem. 2016 Nov 10;59(21):9855-9865. Epub 2016 Oct 24.

PMID:
27731639
17.

Inhibition of Rho-Associated Kinase 1/2 Attenuates Tumor Growth in Murine Gastric Cancer.

Hinsenkamp I, Schulz S, Roscher M, Suhr AM, Meyer B, Munteanu B, Fuchser J, Schoenberg SO, Ebert MP, Wängler B, Hopf C, Burgermeister E.

Neoplasia. 2016 Aug;18(8):500-11. doi: 10.1016/j.neo.2016.07.002.

18.

Physiologically based pharmacokinetic modeling of (18)F-SiFAlin-Asp3-PEG1-TATE in AR42J tumor bearing mice.

Maaß C, Rivas JR, Attarwala AA, Hardiansyah D, Niedermoser S, Litau S, Wängler C, Wängler B, Glatting G.

Nucl Med Biol. 2016 Apr;43(4):243-6. doi: 10.1016/j.nucmedbio.2016.01.001. Epub 2016 Jan 7.

PMID:
27067044
19.

From Unorthodox to Established: The Current Status of (18)F-Trifluoroborate- and (18)F-SiFA-Based Radiopharmaceuticals in PET Nuclear Imaging.

Bernard-Gauthier V, Bailey JJ, Liu Z, Wängler B, Wängler C, Jurkschat K, Perrin DM, Schirrmacher R.

Bioconjug Chem. 2016 Feb 17;27(2):267-79. doi: 10.1021/acs.bioconjchem.5b00560. Epub 2015 Nov 25. Review.

PMID:
26566577
20.

Next Generation of SiFAlin-Based TATE Derivatives for PET Imaging of SSTR-Positive Tumors: Influence of Molecular Design on In Vitro SSTR Binding and In Vivo Pharmacokinetics.

Litau S, Niedermoser S, Vogler N, Roscher M, Schirrmacher R, Fricker G, Wängler B, Wängler C.

Bioconjug Chem. 2015 Dec 16;26(12):2350-9. doi: 10.1021/acs.bioconjchem.5b00510. Epub 2015 Oct 14.

PMID:
26420336

Supplemental Content

Loading ...
Support Center